Bluelinx Holdings, Inc. (BXC) Reports Q4 Loss of $0.17, Sales Rose 6.3% Y/Y
Get Alerts BXC Hot Sheet
Join SI Premium – FREE
Bluelinx Holdings, Inc. (NYSE: BXC) reported Q4 EPS of ($0.17), versus ($0.66) reported last year. Revenue for the quarter came in at $391.1 million, versus $367.9 million reported last year.
For earnings history and earnings-related data on Bluelinx Holdings, Inc. (BXC) click here.
For earnings history and earnings-related data on Bluelinx Holdings, Inc. (BXC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Ferroglobe (GSM) Misses Q3 EPS by 3c
- Spyre Therapeutics, Inc. (SYRE) Misses Q3 EPS by 16c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share